DreaMed Diabetes develops decision-support tools for diabetes management, pioneering the first artificial pancreas technology
DreaMed Diabetes develops decision-support tools for diabetes management, pioneering the first artificial pancreas technology. Its core product, endo.digital, is a cloud-based SaaS platform that provides healthcare organizations with an end-to-end diabetes care pathway solution. The platform utilizes advanced AI and analytics to transform patient data from continuous glucose monitoring, self-monitoring of blood glucose, and insulin pumps into expert-level treatment recommendations.